These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1994787)

  • 1. A pilot study of pemirolast in patients with seasonal allergic rhinitis.
    Tinkelman DG; Berkowitz RB
    Ann Allergy; 1991 Feb; 66(2):162-5. PubMed ID: 1994787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
    Abelson MB; Berdy GJ; Mundorf T; Amdahl LD; Graves AL;
    J Ocul Pharmacol Ther; 2002 Oct; 18(5):475-88. PubMed ID: 12419098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive activity of pemirolast potassium, an antiallergic drug, on glomerulonephritis. Studies in glomerulonephritis model rats and in patients with chronic glomerulonephritis concurrently affected by allergic rhinitis.
    Gohda T; Ra C; Hamada C; Tsuge T; Kawachi H; Tomino Y
    Arzneimittelforschung; 2008; 58(1):18-23. PubMed ID: 18368946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemirolast, a new oral nonbronchodilator drug for chronic asthma.
    Kemp JP; Bernstein IL; Bierman CW; Li JT; Siegel SC; Spangenberg RD; Tinkelman DG
    Ann Allergy; 1992 Jun; 68(6):488-91. PubMed ID: 1610024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis.
    Dolovich J; Moote DW; Mazza JA; Clermont A; PetitClerc C; Danzig M
    Ann Allergy; 1994 Sep; 73(3):235-9. PubMed ID: 8092558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
    Miyake-Kashima M; Takano Y; Tanaka M; Satake Y; Kawakita T; Dogru M; Asano-Kato N; Fukagawa K; Fujishima H
    Jpn J Ophthalmol; 2004; 48(6):587-90. PubMed ID: 15592786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
    Kurowski M; Kuna P; Górski P
    Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
    Jen A; Baroody F; de Tineo M; Haney L; Blair C; Naclerio R
    J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis.
    Gibbs TG; McDonnell KA; Stokes T; Graham AA
    Br J Clin Pract; 1989 Jan; 43(1):11-4. PubMed ID: 2574054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preventive mechanisms and effects of pemirolast potassium on restenosis after percutaneous transluminal coronary angioplasty: serial coronary angiography and intravascular ultrasound studies].
    Yoshinuma M
    J Cardiol; 1999 Feb; 33(2):81-8. PubMed ID: 10087476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis.
    Tinkelman D; Falliers C; Gross G; Segal A; Southern L; Welch M; Yeates H; Gorder J; Garcia J
    Ann Allergy; 1990 Feb; 64(2 Pt 2):234-40. PubMed ID: 2405747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J; Halverson PC; Meltzer EO; Shoenwetter WF; van Bavel JH; Woehler TR; Freitag JJ; Hemsworth GR
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.
    Grossman J; Bronsky EA; Lanier BQ; Linzmayer MI; Moss BA; Schenkel EJ; Selner JC
    Ann Allergy; 1989 Oct; 63(4):317-21. PubMed ID: 2529798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preseasonal prophylactic treatment with antihistamines suppresses nasal symptoms and expression of histamine H₁ receptor mRNA in the nasal mucosa of patients with pollinosis.
    Mizuguchi H; Kitamura Y; Kondo Y; Kuroda W; Yoshida H; Miyamoto Y; Hattori M; Fukui H; Takeda N
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32(10):745-8. PubMed ID: 21225011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.